Bioresorbable Stents

Global Market Trajectory & Analytics

MCP10697

EXECUTIVE ENGAGEMENTS

* Login for a full stack data experience

DATE

MAY 2021

TABLES

32

125

EDITION

7

PRICE

USD 4950

CODE

MCP10697

*Engagement stats are ongoing and dynamic

COMPETITIVE METRICS

COMPANY	RANK & SHARE D S N T	% *

SUBMIT

* D = Dominant; S = Strong; N = Niche; T = Trivial (< 1%)

* Validated participants will receive complimentary Cluster data by email

Note: Best viewed in Landscape Mode

VIEW ENTIRE POOL OF 25 COMPETITORS

Sign-in with email to View Deeper Validated Engagement Details -

RESEARCH MODULES MARKET TRENDS EXECUTIVES

HIGHLIGHTS & REPORT INDEX

Global Bioresorbable Stents Market to Reach $691.6 Million by 2027

Amid the COVID-19 crisis, the global market for Bioresorbable Stents estimated at US$316.7 Million in the year 2020, is projected to reach a revised size of US$691.6 Million by 2027, growing at a CAGR of 11% over the analysis period 2021-2027. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is projected to reach US$499.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metal-based Bioresorbable Stents segment is readjusted to a revised 10% CAGR for the next 7-year period.

European Market is Estimated at $170.6 Million, While Asia-Pacific is Forecast to Grow at 10.3% CAGR

Bioresorbable Stents market in Europe is estimated at US$170.6 Million in the year 2020. Asia-Pacific is forecast to reach a projected market size of US$176.2 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Rest of World is forecast to grow at 11.1% over the 2020-2027 period.

SELECT PLAYERS

Abbott Laboratories; Arterius Limited; BIOTRONIK SE & Co. KG; Boston Scientific Corporation; Elixir Medical Corp.; Kyoto Medical Planning Co., Ltd.; LEPU MEDICAL TECHNOLOGY CO., LTD.; Meril Life Sciences Pvt. Ltd.; REVA Medical, Inc.

SEGMENTS

» Material (Polymer-based, Metal-based) » Application (Coronary Artery Disease/CAD, Peripheral Artery Disease/PAD) » End-Use (Hospitals, Cardiovascular Centers)

GEOGRAPHIES

» World » Europe » Asia-Pacific » Rest of World

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Coronary Artery Disease (CAD) – A Perspective

Causes and Symptoms

Treatment Options for Coronary Artery Disease

Percutaneous Coronary Intervention (PCI)

Coronary Stenting

Types of Coronary Stents

Other Treatment Options for Coronary Heart Disease

Coronary Artery Bypass Grafting (CABG)

Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)

TransMyocardial Laser Revascularization (TMR)

Peripheral Arterial Disease: Understanding the Stealthy Peril

Treatment for PAD

Stenting- A Treatment Option for PAD

BioResorbable Stents – A Prelude

Bioresorbable Vascular Scaffolds: Advantages and Challenges

Bioresorbable Stents – A Revolutionary Technology, Riddled with Controversies

Abbott Stops Sales of the Once Promising ‘Absorb’ Bioresorbable Stents due to Adverse Events

Impact of Abbott’s Withdrawal of Absorb on the Bioresorbable Stent Industry

Impact of Covid-19 and a Looming Global Recession

2020 Marked as a Year of Disruption & Transformation

EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022

Impact of COVID – 19 on Coronary Stents Market

Impact on Supply Chain

Impact of COVID-19 Outbreak on Elective Surgeries

Global Bioresorbable Stents Market Buckles under COVID-19 Strain

GLOBAL MARKET OVERVIEW

Global Bioresorbable Stents Set to Witness Growth in Future

Europe Dominates, Asia-Pacific Exhibits Fastest Growth

CAD Constitutes the Leading Application

Metallic Vs. Polymer-based Stents

Bioabsorbable Metallic Stents

Bioabsorbable Polymer Stents

Disappointing Results by Absorb to Increase Focus on Metallic Stents

Availability of Alternative Treatments – Hindrance to Market Growth

Market Challenges

MARKET OUTLOOK

Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents

The Future of BRS Technology

COMPETITION

Select Approved Bioresorbable Scaffolds

Select Bioresorbable Stents in Pipeline

Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate New Esprit Scaffold

Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Polymeric Resorbable Scaffolds Hold a Major Market Share

The Absorb BRS program

Desaminotyrosine Polycarbonate-based BRS

The FANTOM program

Magnesium-based BRS

The Magmaris program

Iron-based BRS

Global Menace of Coronary Artery Disease (CAD) – A Major Growth Driver

EXHIBIT: Global Annual Medical Cost of CVD in the United States: 2015-2030

EXHIBIT: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others

Ageing Demographics and Longer Life Expectancy Bolsters Market Growth

EXHIBIT: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050

EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030

Rising Middle Class Population Aids Growth

EXHIBIT: Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020P & 2030P

Rising Healthcare Expenditure: Opportunities in Store

EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023

EXHIBIT 3: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023

Risk of CAD in Obesity Offers Prospects for Coronary Stenting

EXHIBIT: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P

Diabetics at Higher Risk of Heart Diseases

TABLE 15: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040

The Hypertension-Cholesterol Link to Drive Demand

EXHIBIT: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years

Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents

Metal Stents Vis-à-Vis Other Stents

4. GLOBAL MARKET PERSPECTIVE

World Current & Future Analysis for Bioresorbable Stents by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Bioresorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027

World Current & Future Analysis for Polymer-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Metal-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Metal-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Coronary Artery Disease/CAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Coronary Artery Disease/CAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Peripheral Artery Disease/PAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Peripheral Artery Disease/PAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Hospitals by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

World Current & Future Analysis for Cardiovascular Centers by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

World 7-Year Perspective for Cardiovascular Centers by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

EUROPE

Europe Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027

Europe Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027

Europe Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Europe 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027

ASIA-PACIFIC

Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027

Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027

Asia-Pacific Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Asia-Pacific 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027

REST OF WORLD

Rest of World Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027

Rest of World Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027

Rest of World Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Rest of World 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 25

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.